Page 1701 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 93 Late Complications of Hematologic Diseases and Their Therapies 1512.e7

260. van Leeuwen FE, Klokman WJ, Stovall M, et al: Roles of radiation four decades–experience from the Nordic countries. Int J Cancer
dose, chemotherapy, and hormonal factors in breast cancer following 131(7):1659–1666, 2012.
Hodgkin’s disease. J Natl Cancer Inst 95(13):971–980, 2003. 282. Martin PJ, Counts GW, Jr, Appelbaum FR, et al: Life expectancy in
261. Friedman DL, Rovo A, Leisenring W, et al: Increased risk of breast patients surviving more than 5 years after hematopoietic cell transplan-
cancer among survivors of allogeneic hematopoietic cell transplanta- tation. J Clin Oncol 28(6):1011–1016, 2010.
tion: a report from the FHCRC and the EBMT-Late Effect Working 283. Wingard JR, Majhail NS, Brazauskas R, et al: Long-term survival and
Party. Blood 111(2):939–944, 2008. late deaths after allogeneic hematopoietic cell transplantation. J Clin
262. Reulen RC, Taylor AJ, Winter DL, et al: Long-term population-based Oncol 29(16):2230–2239, 2011.
risks of breast cancer after childhood cancer. Int J Cancer 123(9):2156– 284. Socie G, Stone JV, Wingard JR, et al: Long-term survival and late
2163, 2008. deaths after allogeneic bone marrow transplantation. Late Effects
263. Travis LB, Hill D, Dores GM, et al: Cumulative absolute breast cancer Working Committee of the International Bone Marrow Transplant
risk for young women treated for Hodgkin lymphoma. J Natl Cancer Registry. N Engl J Med 341(1):14–21, 1999.
Inst 97(19):1428–1437, 2005. 285. Vanderwalde AM, Sun CL, Laddaran L, et al: Conditional survival and
264. Bhatia S, Sklar C: Second cancers in survivors of childhood cancer. Nat cause-specific mortality after autologous hematopoietic cell transplan-
Rev Cancer 2(2):124–132, 2002. tation for hematological malignancies. Leukemia 27(5):1139–1145,
265. Sigurdson AJ, Ronckers CM, Mertens AC, et al: Primary thyroid cancer 2013.
after a first tumour in childhood (the Childhood Cancer Survivor 286. Kunin-Batson A, Kadan-Lottick N, Neglia JP: The contribution of
Study): a nested case-control study. Lancet 365(9476):2014–2023, neurocognitive functioning to quality of life after childhood acute
2005. lymphoblastic leukemia. Psychooncology 23(6):692–699, 2014.
266. Ronckers CM, Sigurdson AJ, Stovall M, et al: Thyroid cancer in child- 287. Zebrack BJ, Zeltzer LK, Whitton J, et al: Psychological outcomes in
hood cancer survivors: a detailed evaluation of radiation dose response long-term survivors of childhood leukemia Hodgkin’s disease, and non-
and its modifiers. Radiat Res 166(4):618–628, 2006. Hodgkin’s lymphoma: a report from the Childhood Survivor Study.
267. Bhatti P, Veiga LH, Ronckers CM, et al: Risk of second primary thyroid Pediatrics 110:42–52, 2002.
cancer after radiotherapy for a childhood cancer in a large cohort 288. Stuber ML, Meeske KA, Krull KR, et al: Prevalence and predictors of
study: an update from the childhood cancer survivor study. Radiat Res posttraumatic stress disorder in adult survivors of childhood cancer.
174(6):741–752, 2010. Pediatrics 125(5):e1124–e1134, 2010.
268. Neglia JP, Robison LL, Stovall M, et al: New primary neoplasms 289. Loge JH, Abrahamsen AF, Ekeberg O, et al: Reduced health-related
of the central nervous system in survivors of childhood cancer: a quality of life among Hodgkin’s disease survivors: a comparative
report from the Childhood Cancer Survivor Study. J Natl Cancer Inst study with general population norms. Ann Oncol 10(1):71–77,
98(21):1528–1537, 2006. 1999.
269. Little MP, de Vathaire F, Shamsaldin A, et al: Risks of brain tumour 290. Kornblith AB, Herndon JE, 2nd, Zuckerman E, et al: Comparison
following treatment for cancer in childhood: modification by genetic of psychosocial adaptation of advanced stage Hodgkin’s disease and
factors, radiotherapy and chemotherapy. Int J Cancer 78(3):269–275, acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol
1998. 9(3):297–306, 1998.
270. Goshen Y, Stark B, Kornreich L, et al: High incidence of meningioma in 291. Knobel H, Havard Loge J, Brit Lund M, et al: Late medical com-
cranial irradiated survivors of childhood acute lymphoblastic leukemia. plications and fatigue in Hodgkin’s disease survivors. J Clin Oncol
Pediatr Blood Cancer 49(3):294–297, 2007. 19(13):3226–3233, 2001.
271. Ron E, Modan B, Boice JD, Jr, et al: Tumors of the brain and nervous 292. Green DM, Zevon MA, Rock KM, et al: Fatigue after treatment for
system after radiotherapy in childhood. N Engl J Med 319(16):1033– Hodgkin’s disease during childhood or adolescence. Proceedings of the
1039, 1988. American Society of Clinical Oncology 21:396a, 2002.
272. Bowers DC, Nathan PC, Constine L, et al: Subsequent neoplasms of 293. Loge JH, Abrahamsen AF, Ekeberg O, et al: Hodgkin’s disease survivors
the CNS among survivors of childhood cancer: a systematic review. more fatigued than the general population. J Clin Oncol 17(1):253–261,
Lancet Oncol 14(8):e321–e328, 2013. 1999.
273. Taylor AJ, Little MP, Winter DL, et al: Population-based risks of CNS 294. Neitzert CS, Ritvo P, Dancey J, et al: The psychosocial impact of
tumors in survivors of childhood cancer: the British Childhood Cancer bone marrow transplantation: a review of the literature. Bone Marrow
Survivor Study. J Clin Oncol 28(36):5287–5293, 2010. Transplant 22(5):409–422, 1998.
274. Leisenring W, Friedman DL, Flowers ME, et al: Nonmelanoma skin 295. Andrykowski MA, Schmitt FA, Gregg ME, et al: Neuropsychologic
and mucosal cancers after hematopoietic cell transplantation. J Clin impairment in adult bone marrow transplant candidates. Cancer
Oncol 24(7):1119–1126, 2006. 70(9):2288–2297, 1992.
275. Schwartz JL, Kopecky KJ, Mathes RW, et al: Basal cell skin cancer after 296. Syrjala KL, Roth-Roemer SL, Abrams JR, et al: Prevalence and predic-
total-body irradiation and hematopoietic cell transplantation. Radiat tors of sexual dysfunction in long-term survivors of marrow transplanta-
Res 171(2):155–163, 2009. tion. J Clin Oncol 16(9):3148–3157, 1998.
276. Atahan IL, Yildiz F, Ozyar E, et al: Basal cell carcinomas developing in 297. Land VJ, Shuster JJ, Crist WM, et al: Comparison of two schedules
a case of medulloblastoma associated with Gorlin’s syndrome. Pediatr of intermediate-dose methotrexate and cytarabine consolidation
Hematol Oncol 15(2):187–191, 1998. therapy for childhood B-precursor cell acute lymphoblastic leukemia:
277. Olsen JH, Garwicz S, Hertz H, et al: Second malignant neoplasms after a Pediatric Oncology Group study. J Clin Oncol 12(9):1939–1945,
cancer in childhood or adolescence. Nordic Society of Paediatric Hae- 1994.
matology and Oncology Association of the Nordic Cancer Registries. 298. Uderzo C, Valsecchi MG, Balduzzi A, et al: Allogeneic bone marrow
BMJ 307:1030–1036, 1993. transplantation versus chemotherapy in high-risk childhood acute
278. Perkins JL, Liu Y, Mitby PA, et al: Nonmelanoma skin cancer in survi- lymphoblastic leukaemia in first remission. Associazione Italiana di
vors of childhood and adolescent cancer: a report from the childhood Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano
cancer survivor study. J Clin Oncol 23(16):3733–3741, 2005. Trapianto di Midollo Osseo (GITMO). Br J Haematol 96(2):387–394,
279. Saslow D, Boetes C, Burke W, et al: American Cancer Society guide- 1997.
lines for breast screening with MRI as an adjunct to mammography. 299. Oh H, Gale RP, Zhang MJ, et al: Chemotherapy vs HLA-identical
CA Cancer J Clin 57(2):75–89, 2007. sibling bone marrow transplants for adults with acute lymphoblastic
280. Reulen RC, Winter DL, Frobisher C, et al: Long-term cause-specific leukemia in first remission. Bone Marrow Transplant 22(3):253–257,
mortality among survivors of childhood cancer. JAMA 304(2):172–179, 1998.
2010. 300. Fulbright JM, Raman S, McClellan WS, et al: Late effects of child-
281. Garwicz S, Anderson H, Olsen JH, et al: Late and very late mortal- hood leukemia therapy. Curr Hematol Malig Rep 6(3):195–205,
ity in 5-year survivors of childhood cancer: changing pattern over 2011.